Page last updated: 2024-11-01

5-nitro-2-(3-phenylpropylamino)benzoic acid and Hypothyroidism

5-nitro-2-(3-phenylpropylamino)benzoic acid has been researched along with Hypothyroidism in 1 studies

5-nitro-2-(3-phenylpropylamino)benzoic acid: structure given in first source; chloride channel antagonist

Hypothyroidism: A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dossena, S1
Vezzoli, V1
Cerutti, N1
Bazzini, C1
Tosco, M1
Sironi, C1
Rodighiero, S1
Meyer, G1
Fascio, U1
Fürst, J1
Ritter, M1
Fugazzola, L1
Persani, L1
Zorowka, P1
Storelli, C1
Beck-Peccoz, P1
Bottà, G1
Paulmichl, M1

Other Studies

1 other study available for 5-nitro-2-(3-phenylpropylamino)benzoic acid and Hypothyroidism

ArticleYear
Functional characterization of wild-type and a mutated form of SLC26A4 identified in a patient with Pendred syndrome.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2006, Volume: 17, Issue:5-6

    Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Biological Transport; Cells, Cultured; Chlorides;

2006